A new entrant in the race to shepherd antibodies for Alzheimer’s disease across the blood-brain barrier has emerged. | A new entrant in the race to shepherd antibodies for Alzheimer’s disease across ...
Backed by Wellington, Sanofi Ventures and a division of J.P. Morgan, Korsana Therapeutics is studying a treatment originally developed by hub-and-spoke biotech Paragon Therapeutics.
Well, investors at Fairmount, Venrock, Wellington Management, and TCGX believe so. They and other firms have handed $175 ...
A team of UC Santa Barbara engineering and molecular biology graduate students has developed software to accelerate the discovery process for therapies ...
A Georgia Tech researcher is turning flickering light and sound into a new tool in the fight against Alzheimer’s, using rhythmic sensory stimulation to “tune” brain waves, boost memory, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results